These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diversity and variability of the effects of nicotine on different cortical regions of the brain - therapeutic and toxicological implications. Toledano A; Alvarez MI; Toledano-Díaz A Cent Nerv Syst Agents Med Chem; 2010 Sep; 10(3):180-206. PubMed ID: 20528766 [TBL] [Abstract][Full Text] [Related]
3. Molecular and cellular mechanisms of action of nicotine in the CNS. Barik J; Wonnacott S Handb Exp Pharmacol; 2009; (192):173-207. PubMed ID: 19184650 [TBL] [Abstract][Full Text] [Related]
4. Multiple brain pathways and receptors underlying tobacco addiction. Rose JE Biochem Pharmacol; 2007 Oct; 74(8):1263-70. PubMed ID: 17826746 [TBL] [Abstract][Full Text] [Related]
9. Nicotinic modulation of neuronal networks: from receptors to cognition. Mansvelder HD; van Aerde KI; Couey JJ; Brussaard AB Psychopharmacology (Berl); 2006 Mar; 184(3-4):292-305. PubMed ID: 16001117 [TBL] [Abstract][Full Text] [Related]
10. Effect of nicotine and nicotinic receptors on anxiety and depression. Picciotto MR; Brunzell DH; Caldarone BJ Neuroreport; 2002 Jul; 13(9):1097-106. PubMed ID: 12151749 [TBL] [Abstract][Full Text] [Related]
11. Nicotine as a discriminative stimulus: a neurobehavioral approach to studying central cholinergic mechanisms. Rosecrans JA J Subst Abuse; 1989; 1(3):287-300. PubMed ID: 2535609 [TBL] [Abstract][Full Text] [Related]
12. Biological aspects of the link between smoking and depression. Quattrocki E; Baird A; Yurgelun-Todd D Harv Rev Psychiatry; 2000 Sep; 8(3):99-110. PubMed ID: 10973935 [TBL] [Abstract][Full Text] [Related]
13. Neuronal nicotinic receptors as brain targets for pharmacotherapy of drug addiction. Rahman S; López-Hernández GY; Corrigall WA; Papke RL CNS Neurol Disord Drug Targets; 2008 Nov; 7(5):422-41. PubMed ID: 19128201 [TBL] [Abstract][Full Text] [Related]
14. Cellular mechanisms of nicotine addiction. Dani JA; De Biasi M Pharmacol Biochem Behav; 2001 Dec; 70(4):439-46. PubMed ID: 11796143 [TBL] [Abstract][Full Text] [Related]
15. Fetal nicotine or cocaine exposure: which one is worse? Slotkin TA J Pharmacol Exp Ther; 1998 Jun; 285(3):931-45. PubMed ID: 9618392 [TBL] [Abstract][Full Text] [Related]
16. Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders. Balfour DJ; Fagerström KO Pharmacol Ther; 1996; 72(1):51-81. PubMed ID: 8981571 [TBL] [Abstract][Full Text] [Related]
17. Tobacco smoking and nicotine neuropsychopharmacology: some future research directions. Domino EF Neuropsychopharmacology; 1998 Jun; 18(6):456-68. PubMed ID: 9571654 [TBL] [Abstract][Full Text] [Related]